Here, we report a microbiological assay using large plates designed to determine potency and concentration of pharmaceutical-grade antibiotics for injection and a statistical method to assess the ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

“Complex” media are used in the growth of a majority of heterotrophic organisms; “defined” media are used for microbiological assays, photoautotrophs, chemoautotrophs, and for growing ...

Credible reference materials can help identify and normalize sources of assay bias and improve the consistency and reproducibility of data. The human body harbors diverse, dynamic microbial ...

QIAGEN has introduced two tools designed to advance microbial analysis by allowing researchers to customise their assays and panels. These tools are compatible with QIAcuity digital polymerase ...

Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances Newly found ...

[32] To show the ability of the microbiological assay to unambiguously assess the API in presence of all other expected components in a pharmaceutical-grade product for clinical use (specificity ...